Adventist Health System/Sunbelt, Inc.
Date of Award
Type 1 Diabetes, Prevent & Delay
Term of Grant
Determining whether a class of drugs, GPR119 agonists, might prevent hypoglycemia in type 1 diabetes (proof of pharmacology)
Funds to support a clinical study to determine whether a class of drugs, GPR119 agonists, could reverse low blood glucose levels (hypoglycemia) in type 1 diabetes (T1D).